Auricular Acupuncture in Patients With Advanced Cancer: a Randomized Clinical Trial.
NCT ID: NCT05762250
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
125 participants
INTERVENTIONAL
2023-08-13
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupressure for Fatigue in Elderly Cancer Patients
NCT04362904
Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study
NCT00487331
Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
NCT03640195
Acupuncture for Insomnia in Breast Cancer Patients Undergoing Chemotherapy
NCT04144309
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment
NCT02754752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Auricular Acupuncture
Intervention group: Ear acupressure is performed on both ears with permanent pellets according to the NADA (National Acupuncture Detoxification Association) protocol over a period of 8 weeks (presentation at the study center 1x/week, application of the acupressure patches there; these remain on both ears for 5 days and should be massaged 3x/day by the patients themselves according to the instructions provided).
In addition, patients receive a 30-minute psychoeducational talk at the first treatment appointment to promote their own health competence.
Auricular Acupuncture
Within the NADA protocol, 5 defined points on the patient's ears are treated according to a standardized concept (shen men, kidney, lung, liver, vegetative I).
Waitlist
Control group: standard treatment / waiting list Patients in the control group will also receive a one-time 30-minute psychoeducational interview at baseline.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auricular Acupuncture
Within the NADA protocol, 5 defined points on the patient's ears are treated according to a standardized concept (shen men, kidney, lung, liver, vegetative I).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent.
Exclusion Criteria
* a mental condition which, in the opinion of the investigator, does not allow the patient to participate in the study,
* a planned radiation therapy in the area of the skull (to avoid potential scattered radiation),
* a missing legally binding signature on the informed consent form,
* participation in another acupuncture/acupressure study.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
OTHER
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Loeffler, Dr
Role: PRINCIPAL_INVESTIGATOR
University Hospital Wuerzburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert Bosch Krankenhaus
Stuttgart, , Germany
University Hospital Wuerzburg
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Marcela Winkler, MD
Role: primary
Claudia Loeffler, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S00776
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.